Kevin Keane Email & Phone Number

Cambridge, MA, US

Cambridge, Massachusetts, US

I am responsible for the pathology portions of Blueprint Medicines portfolio in nonclinical development for novel therapies to treat life-threatening diseases with kinase inhibitors in genetically defined cancers. This includes extensive interactions with our CRO partners and internal projects for safety and efficacy testing.

Toxicologic Pathology, published by Sage Publishing, is the official journal of the STP, ESTP, and BSTP. I have overall responsibility for both the daily operations, scholarly quality, and publishing integrity of the primary scholarly journal in the scientific discipline of toxicologic pathology. My responsibilities include management of a paid staff of.

The associate editors are responsible for the day-to-day operations of the peer review process of scholarly, investigative and review manuscripts submitted to the journal. This includes communications with submitting authors, identification of expert peer reviewers, and management of the revision process and ultimately recommending to the Editor-in-Chief.

I was elected by other Fellows to serve as President of the International Academy of Toxicologic Pathology from 2021 to 2023. As the immediate past president, I continue to serve as voting member of the board of directors who serves to support the current president and promote the mission of the Academy.

The International Academy of Toxicologic Pathology (IATP) is a global professional scientific organization that establishes the criteria of excellence and accomplishments in toxicologic pathology for accreditation of members (fellows), serves as a worldwide source of experts in toxicologic pathology and organizes unique educational opportunities for.

Bagsværd, DK

During my last 3 years of living in Denmark, I was the toxicologic pathologist for the Novo Nordisk Stem Cell Transformational Research Unit. This was a biotech-like group of cell biologist, medical device engineers, molecular biologist, physicians, pharmacologists, CMC and nonclinical development experts who are using Novo Nordisk's decades of cell.

Bagsværd, DK

My initial role in Denmark at NN's R&D headquarters was as a principal scientist in pathology with a primary duty as a toxicologic pathology expert in the design, execution, interpretation, and reporting of toxicology studies. This position required extensive interactions with contract research organizations (CROs) which conduct the GLP-compliant.

Bagsværd, DK

The Novo Nordisk Beijing R&D centre is dedicated to using our expertise in protein technology, pharmacology, and disease models to advance our company's pipeline in diabetes, obesity, hemophilia, growth disorders, and diabetic complications. I am a principal scientist who is responsible for the preliminary safety assessment of novel drug target candidates.

Dr. Keane is a toxicologic pathologist with broad experiences conducting safety studies in nonclinical drug development, environmental chemicals, and medical devices. He has worked throughout North America, China, and Europe and uses his own expertise in collaboration with a network of safety assessment colleagues to facilitate GLP-compliant studies for.

Huntingdon, Cambridgeshire, GB

Responsible for the overall management of the pathology department in its mission to produce timely, high-quality, compliant toxicologic and cost-effective pathology reports. Supervise six anatomical pathologists and one administrative scheduler. Foster an environment of scientific excellence in a GLP-compliant facility. Train staff members in the gross.

Reston, VA, US

My term as overall chairperson of the STP Education Committee was completed in 2012. I have currently shifted my focus to the subcommittee responsible for organizing modular education for new pathologists. This program will be a rotating series of courses that will train entry level pathologist in the art & science of toxicologic pathology. The program is.

Assumed additional responsibilities beyond those previously described. Current responsibilities are as the Facility Laboratory Animal Veterinarian responsible for welfare of animals and regulatory compliance in a 40000 square foot vivarium housing mice, rats, rabbits, dogs, and cynomolgus macaques.Additional duties are those of Drug Safety Compound Leader.

Kenilworth, New Jersey, US

Veterinary pathologist in the Division of Drug Safety working on the development of novel therapeutics in GLP environment. Responsibilities include the assessment of tissues in acute and chronic toxicity studies, including 2-year carcinogenicity assays, peer-review of CRO studies, and collaboration on drug discovery projects.

US

Veterinary pathologist at the 500 person biotech company which developed Cialis®. Responsibilities include direct supervision of the histology and image analysis laboratory and three individuals, which service a variety of research and development projects and include necropsy, histopathology, immunohistochemistry, in situ hybridization, and computer.

Ph.D., Pathology

Residency In Anatomical Pathology, Veterinary Pathology And Pathobiology

Dvm, Veterinary Medicine

Ba, Biology